En esta página
01ERAS precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
ERAS Erasca, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$14,74
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,11mínimo 52 semanas
$24,28máximo 52 semanas
Capitalización Bursátil (MRQ)
$4.61B
P/E
-33.5
BPA
$-0.44
tus insignias
Rango 52S
$2–$24
Calificación del Analista
BUY
Precio Objetivo
$24
P/E
-33.5
ROE
-35.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ERAS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$14.74
Capitalización Bursátil (MRQ)
$4.61B
P/E
-33.5
BPA
$-0.44
ROE
-35.7%
Rango 52S
$2–$24
ERAS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.442021-12-31 → 2025-12-31
Flujo de caja libre$-96M2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ERAS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -33.5promedio 5A ≈-5.0 | ≈-5.0 | · | · | |
| P/C (MRQ) | 12.7promedio 5A ≈2.3 | ≈2.3 | 5.2 | Sobrevalorado | |
| Precio / FCF (TTM) | -47.0promedio 5A ≈-9.3 | ≈-9.3 | · | · | |
| Precio / Flujo de Caja (TTM) | -47.0promedio 5A ≈-10.1 | ≈-10.1 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 12.9promedio 5A ≈2.3 | ≈2.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ERAS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -27.7%promedio 5A ≈-35.6% | ≈-35.6% | -25.8% | En línea | |
| ROE | -35.7%promedio 5A ≈-39.9% | ≈-39.9% | -38.2% | En línea | |
| ROIC | -43.3% | · | -9.7% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ERAS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 8.3promedio 5A ≈11.4 | ≈11.4 | 8.9 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 9.7promedio 5A ≈11.2 | ≈11.2 | 8.0 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-34.1%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.14 | $-0.10 | -34.7% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.60 | $-0.21 | -181.6% |
| 31 de diciembre de 2025 | $-0.10 | $-0.11 | 8.3% | |
| 30 de septiembre de 2025 | $-0.11 | $-0.11 | -4.4% | |
| 30 de junio de 2025 | $-0.12 | $-0.11 | -7.0% | |
| 31 de marzo de 2025 | $-0.11 | $-0.13 | 14.4% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $39M | $42M | $38M | $33M | $23M | $8M | |
| Operating Expenses | $141M | $180M | $142M | $247M | $125M | $109M | |
| Operating Income | $-141M | $-180M | $-142M | $-247M | $-125M | $-109M | |
| Other Non-op | $16M | $18M | $16M | $5M | $314.0K | $-102.0K | |
| Pretax Income | $-125M | $-162M | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M | $-102M | |
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| EPS (Diluted) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| Shares (Basic) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| Shares (Diluted) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| EBITDA | $-138M | $-176M | $-138M | $-245M | $-124M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $68M | $93M | $284M | $360M | $65M | |
| Short-term Investments | $202M | $231M | $219M | $151M | $54M | $53M | |
| Prepaid Expense | $10M | $10M | $8M | $9M | $6M | $1M | |
| Current Assets | $286M | $309M | $321M | $444M | $420M | $120M | |
| PP&E (Net) | $13M | $16M | $22M | $25M | $16M | $2M | |
| PP&E (Gross) | $26M | $26M | $30M | $28M | $18M | $3M | |
| Accum. Depreciation | $13M | $10M | $7M | $4M | $2M | $902.0K | |
| Other Non-current Assets | $1M | $3M | $4M | $5M | $3M | $451.0K | |
| Total Assets | $396M | $503M | $395M | $515M | $501M | $125M | |
| Accounts Payable | $981.0K | $468.0K | $2M | $23M | $5M | $878.0K | |
| Current Liabilities | $29M | $31M | $26M | $49M | $26M | $14M | |
| Capital Leases | $42M | $47M | $52M | $54M | $19M | $2M | |
| Other Non-current Liabilities | $399.0K | $362.0K | $566.0K | $573.0K | $158.0K | · | |
| Total Liabilities | $71M | $79M | $79M | $103M | $45M | $17M | |
| Common Stock | $28.0K | $28.0K | $15.0K | $15.0K | $12.0K | $3.0K | |
| Retained Earnings | $-892M | $-768M | $-606M | $-481M | $-238M | $-115M | |
| AOCI | $628.0K | $405.0K | $77.0K | $-1M | $-162.0K | $2.0K | |
| Stockholders' Equity | $325M | $423M | $317M | $412M | $457M | $-114M | |
| Liabilities + Equity | $396M | $503M | $395M | $515M | $501M | $125M | |
| Shares Outstanding | 284,159,076 | 283,218,344 | 151,090,227 | 149,333,258 | 119,102,505 | 21,923,173 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $3M | $829.0K | $540.0K | |
| Stock-based Comp | $25M | $27M | $26M | $20M | $8M | $797.0K | |
| Other Non-cash | $1M | $21M | $-6M | $117M | $34M | · | |
| Operating Cash Flow | $-95M | $-109M | $-101M | $-103M | $-80M | $-33M | |
| CapEx | $128.0K | $60.0K | $2M | $15M | $11M | $947.0K | |
| Investing Cash Flow | $100M | $-157M | $-91M | $-71M | $-65M | $-71M | |
| Stock Issued | · | · | · | $95M | · | · | |
| Net Stock Activity | · | · | · | $95M | · | · | |
| Financing Cash Flow | $1M | $241M | $1M | $98M | $439M | $140M | |
| Net Change in Cash | $6M | $-25M | $-191M | $-76M | $295M | $36M | |
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -27.7% | -36.0% | -27.5% | -47.8% | -39.2% | · | |
| ROE | -35.7% | -37.0% | -38.1% | -62.5% | -26.1% | · | |
| ROIC | -43.3% | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 | · | |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.14 | $1.50 | $2.10 | $2.76 | $3.83 | · | |
| Cash Flow / Share | $-0.34 | $-0.47 | $-0.67 | $-0.85 | · | · | |
| Cash / Share | $0.26 | $0.24 | $0.62 | $1.90 | $3.03 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | |
| EPS (TTM) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-125M | $-162M | $-125M | $-243M | $-123M | · | |
| Market Cap | $1.06B | $711M | $322M | $644M | $1.86B | · | |
| P/E | -8.5 | -3.6 | -2.6 | -2.2 | -8.4 | · | |
| P/B | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Tangible Book | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Cash Flow | -11.1 | -6.5 | -3.2 | -6.2 | -23.3 | · | |
| P / FCF | -11.1 | -6.5 | -3.1 | -5.5 | -20.4 | · | |
| Earnings Yield | -11.8% | -27.5% | -39.0% | -46.2% | -11.9% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $12M | $11M | $9M | $10M | $9M | $10M | $10M | $10M | $12M | $10M | $9M | $9M | $10M | $9M | $9M | $9M | |
| Operating Expenses | $48M | $188M | $33M | $35M | $38M | $36M | $36M | $37M | $68M | $39M | $34M | $35M | $36M | $37M | $138M | $37M | |
| Operating Income | $-48M | $-188M | $-33M | $-35M | $-38M | $-36M | $-36M | $-37M | $-68M | $-39M | $-34M | $-35M | $-36M | $-37M | $-138M | $-37M | |
| Other Non-op | $4M | $22.0K | $7M | $-37.0K | $4M | $-76.0K | $9M | $173.0K | $5M | $4M | $9M | $-49.0K | $4M | $4M | $3M | $1M | |
| Net Income | $-44M | $-183M | $-29M | $-31M | $-34M | $-31M | $-32M | $-31M | $-63M | $-35M | $-30M | $-30M | $-32M | $-33M | $-135M | $-35M | |
| EPS (Basic) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| EPS (Diluted) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| Shares (Basic) | 311,336,806 | 304,317,460 | · | 283,681,570 | 283,355,730 | 283,260,289 | · | 282,384,964 | 217,806,567 | 151,161,741 | · | 150,450,201 | 150,037,029 | 149,504,216 | · | 120,798,322 | |
| Shares (Diluted) | 311,336,806 | 304,317,460 | · | 283,681,570 | 283,355,730 | 283,260,289 | · | 282,384,964 | 217,806,567 | 151,161,741 | · | 150,450,201 | 150,037,029 | 149,504,216 | · | 120,798,322 | |
| EBITDA | $-47M | $-187M | · | $-34M | $-37M | $-35M | · | $-36M | $-67M | $-38M | · | $-34M | $-35M | $-36M | · | $-36M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $47M | $74M | $70M | $66M | $70M | $68M | $69M | $173M | $77M | $93M | $113M | $139M | $273M | $284M | $219M | |
| Short-term Investments | $226M | $197M | $202M | $218M | $235M | $234M | $231M | $250M | $236M | $221M | $219M | $184M | $178M | $117M | $151M | $137M | |
| Prepaid Expense | $10M | $10M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $9M | $7M | $8M | $9M | $10M | |
| Current Assets | $278M | $254M | $286M | $300M | $311M | $315M | $309M | $330M | $418M | $307M | $321M | $306M | $324M | $398M | $444M | $366M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | $21M | $22M | $23M | $24M | $25M | $25M | $25M | |
| PP&E (Gross) | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $30M | $30M | $30M | $29M | $29M | $28M | $27M | |
| Accum. Depreciation | $14M | $13M | $13M | $12M | $11M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Accounts Payable | $2M | $2M | $981.0K | $3M | $2M | $2M | $468.0K | $2M | $2M | $3M | $2M | $4M | $3M | $3M | $23M | $4M | |
| Current Liabilities | $34M | $27M | $29M | $29M | $28M | $25M | $31M | $30M | $25M | $30M | $26M | $27M | $23M | $26M | $49M | $28M | |
| Capital Leases | $39M | $41M | $42M | $43M | $45M | $46M | $47M | $48M | $50M | $51M | $52M | $53M | $54M | $55M | $54M | $53M | |
| Other Non-current Liabilities | $341.0K | $340.0K | $399.0K | $395.0K | $263.0K | $251.0K | $362.0K | $340.0K | $82.0K | $559.0K | $566.0K | $761.0K | $697.0K | $630.0K | $573.0K | · | |
| Total Liabilities | $73M | $68M | $71M | $73M | $73M | $72M | $79M | $79M | $75M | $82M | $79M | $80M | $78M | $81M | $103M | $81M | |
| Common Stock | $31.0K | $31.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $27.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | |
| Retained Earnings | $-1.12B | $-1.08B | $-892M | $-863M | $-833M | $-799M | $-768M | $-735M | $-704M | $-641M | $-606M | $-576M | $-546M | $-514M | $-481M | $-346M | |
| AOCI | $-1M | $-699.0K | $628.0K | $649.0K | $415.0K | $628.0K | $405.0K | $2M | $-196.0K | $-210.0K | $77.0K | $-575.0K | $-793.0K | $-514.0K | $-1M | $-1M | |
| Stockholders' Equity | $362M | $394M | $325M | $348M | $372M | $400M | $423M | $450M | $451M | $288M | $317M | $339M | $363M | $386M | $412M | $365M | |
| Liabilities + Equity | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Shares Outstanding | 312,556,206 | 310,806,888 | 284,159,076 | 283,711,805 | 283,650,139 | 283,265,716 | 283,218,344 | 282,690,975 | 273,039,997 | 151,249,219 | 151,090,227 | 150,537,752 | 150,383,261 | 149,699,528 | 149,333,258 | 121,024,938 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716.0K | $723.0K | $743.0K | $755.0K | $787.0K | $822.0K | $865.0K | $842.0K | $1M | $998.0K | $942.0K | $941.0K | $955.0K | $894.0K | $933.0K | $771.0K | |
| Stock-based Comp | $10M | $8M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | |
| Other Non-cash | · | $147M | · | · | · | $-8M | · | · | · | $-6M | · | · | · | $-898.0K | · | · | |
| Operating Cash Flow | $-27M | $-27M | $-22M | $-22M | $-21M | $-32M | $-25M | $-22M | $-29M | $-33M | $-25M | $-24M | $-26M | $-26M | $-26M | $-24M | |
| CapEx | $8.0K | $36.0K | $9.0K | $6.0K | $30.0K | $83.0K | $0 | $5.0K | $13.0K | $42.0K | $82.0K | $240.0K | $247.0K | $1M | $864.0K | $2M | |
| Investing Cash Flow | $19M | $-244M | $25M | $26M | $16M | $34M | $23M | $-103M | $-87M | $10M | $5M | $-2M | $-109M | $15M | $-5M | $-55M | |
| Stock Issued | $0 | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $245M | $575.0K | $41.0K | $447.0K | $33.0K | $801.0K | $21M | $212M | $7M | $456.0K | $7.0K | $649.0K | $183.0K | $96M | $427.0K | |
| Net Change in Cash | $-5M | $-27M | $4M | $4M | $-4M | $3M | $-1M | $-104M | $96M | $-16M | $-20M | $-26M | $-134M | $-11M | $65M | $-79M | |
| Free Cash Flow | · | $-27M | · | · | · | $-32M | · | · | · | $-33M | · | · | · | $-28M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.0% | -39.3% | · | -6.5% | -7.0% | -7.4% | · | -6.6% | -13.1% | -8.4% | · | -7.0% | -7.2% | -7.0% | · | -7.3% | |
| ROE | -12.0% | -46.3% | · | -7.7% | -8.2% | -9.0% | · | -7.9% | -15.5% | -10.4% | · | -8.6% | -8.4% | -8.2% | · | -8.4% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 9.5 | · | 10.4 | 11.0 | 12.4 | · | 11.0 | 16.8 | 10.1 | · | 11.4 | 13.9 | 15.6 | · | 13.2 | |
| Quick Ratio | 8.0 | 9.1 | · | 10.0 | 10.7 | 12.0 | · | 10.6 | 16.4 | 9.8 | · | 11.1 | 13.6 | 15.3 | · | 12.9 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $1.27 | · | $1.23 | $1.31 | $1.41 | · | $1.59 | $1.65 | $1.91 | · | $2.25 | $2.41 | $2.58 | · | $3.02 | |
| Cash Flow / Share | · | $-0.09 | · | · | · | $-0.11 | · | · | · | $-0.22 | · | · | · | $-0.18 | · | · | |
| Cash / Share | $0.14 | $0.15 | · | $0.25 | $0.23 | $0.25 | · | $0.24 | $0.63 | $0.51 | · | $0.75 | $0.92 | $1.82 | · | $1.81 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.95 | $-0.93 | · | $-0.40 | $-0.40 | $-0.57 | · | $-0.83 | $-0.92 | $-0.84 | · | $-1.72 | $-1.81 | $-1.90 | · | $-0.85 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-287M | $-277M | · | $-128M | $-128M | $-158M | · | $-159M | $-158M | $-127M | · | $-231M | $-236M | $-240M | · | $-138M | |
| Market Cap | $5.73B | $5.03B | · | $618M | $360M | $388M | · | $772M | $644M | $312M | · | $297M | $415M | $451M | · | $944M | |
| P/E | -19.3 | -17.4 | · | -5.5 | -3.2 | -2.4 | · | -3.3 | -2.6 | -2.5 | · | -1.1 | -1.5 | -1.6 | · | -9.2 | |
| P/B | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Tangible Book | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | -183.6 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -17.1 | · | · | |
| Earnings Yield | -5.2% | -5.8% | · | -18.4% | -31.5% | -41.6% | · | -30.4% | -39.0% | -40.8% | · | -87.3% | -65.6% | -63.1% | · | -10.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-125M | $-162M | $-125M | $-243M | $-123M |
| EPS Diluido | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 |
| Ratio Rápido | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-96M | $-109M | $-103M | $-118M | $-91M |
Propietarios institucionales (13F) 274 declarantes · $4.9B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
274
Valor en tenencia
$4.9B
Nuevas posiciones
66
Posiciones cerradas
26
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 66 (-31 vs trimestre anterior) | 26 (+5 vs trimestre anterior) | 108 (+28 vs trimestre anterior) | 75 (+36 vs trimestre anterior) | +14.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $457 545 444 | 24 975 188 | 9,38% | Acciones |
| BlackRock, Inc. | $387 543 955 | 21 154 146 | 7,94% | Acciones |
| RTW INVESTMENTS, LP | $328 784 533 | 17 946 754 | 6,74% | Acciones |
| Venrock Adviser, LLC | $327 777 996 | 17 891 812 | 6,72% | Acciones |
| STATE STREET CORP | $223 221 048 | 12 184 555 | 4,58% | Acciones |
| Logos Global Management LP | $222 588 000 | 12 150 000 | 4,56% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $208 888 286 | 11 402 199 | 4,28% | Acciones |
| Siren, L.L.C. | $208 807 348 | 11 397 781 | 4,28% | Acciones |
| Paradigm Biocapital Advisors LP | $174 956 000 | 9 550 000 | 3,59% | Acciones |
| ARCH Venture Management, LLC | $129 917 324 | 7 091 557 | 2,66% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $119 128 739 | 6 501 426 | 2,44% | Acciones |
| Cormorant Asset Management, LP | $109 920 000 | 6 000 000 | 2,25% | Acciones |
| Affinity Asset Advisors, LLC | $96 180 000 | 5 250 000 | 1,97% | Acciones |
| Vivo Capital, LLC | $75 614 188 | 4 127 412 | 1,55% | Acciones |
| GOLDMAN SACHS GROUP INC | $70 021 110 | 3 822 113 | 1,44% | Acciones |
| Caption Management, LLC | $68 535 120 | 3 741 000 | 1,40% | Opción de compra |
| ALLIANCEBERNSTEIN L.P. | $66 639 175 | 4 118 614 | 1,37% | Acciones |
| JANUS HENDERSON GROUP PLC | $59 987 765 | 3 710 966 | 1,23% | Acciones |
| BANK OF AMERICA CORP /DE/ | $55 852 862 | 3 048 737 | 1,14% | Acciones |
| FMR LLC | $52 824 202 | 2 883 417 | 1,08% | Acciones |
| a16z Capital Management, L.L.C. | $52 441 000 | 2 862 500 | 1,07% | Acciones |
| Woodline Partners LP | $51 879 803 | 2 831 867 | 1,06% | Acciones |
| JENNISON ASSOCIATES LLC | $51 083 708 | 2 788 412 | 1,05% | Acciones |
| Soleus Capital Management, L.P. | $49 464 000 | 2 700 000 | 1,01% | Acciones |
| VANGUARD GROUP INC | $47 661 220 | 12 812 156 | 0,98% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $43 782 308 | 2 389 864 | 0,90% | Acciones |
| SAMLYN CAPITAL, LLC | $41 347 983 | 2 256 986 | 0,85% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $37 410 063 | 2 042 034 | 0,77% | Acciones |
| NORTHERN TRUST CORP | $35 872 759 | 1 958 120 | 0,74% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35 628 553 | 1 944 790 | 0,73% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $35 475 984 | 1 936 462 | 0,73% | Acciones |
| Nuveen, LLC | $33 740 585 | 1 841 735 | 0,69% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $32 315 360 | 1 763 980 | 0,66% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $31 107 195 | 1 697 991 | 0,64% | Acciones |
| UBS Group AG | $29 250 848 | 1 596 662 | 0,60% | Acciones |
| STEMPOINT CAPITAL LP | $28 687 526 | 1 565 913 | 0,59% | Acciones |
| Rock Springs Capital Management LP | $25 687 388 | 1 402 150 | 0,53% | Acciones |
| Evergreen Quality Fund GP, Ltd. | $25 195 496 | 1 375 300 | 0,52% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $25 078 578 | 1 368 918 | 0,51% | Acciones |
| FRED ALGER MANAGEMENT, LLC | $23 970 896 | 1 308 455 | 0,49% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23 138 636 | 1 263 026 | 0,47% | Acciones |
| Point72 Asset Management, L.P. | $22 848 759 | 1 247 203 | 0,47% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22 780 920 | 1 243 500 | 0,47% | Opción de compra |
| First Turn Management, LLC | $22 381 929 | 1 221 721 | 0,46% | Acciones |
| FEDERATED HERMES, INC. | $19 827 040 | 1 082 262 | 0,41% | Acciones |
| Caption Management, LLC | $19 075 242 | 1 041 225 | 0,39% | Acciones |
| Integral Health Asset Management, LLC | $18 320 000 | 1 000 000 | 0,38% | Acciones |
| D. E. Shaw & Co., Inc. | $17 396 489 | 949 590 | 0,36% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $16 667 792 | 909 814 | 0,34% | Acciones |
| Invesco Ltd. | $15 838 135 | 864 527 | 0,32% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP, Bihua Chen ×4 presentaciones | 30 de enero de 2024 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 14 insiders · 5 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jonathan E Lim | Chairman & CEO | 29 de enero de 2026 A | 12 899 360 | 0 | 0 | $0 |
| David M. Chacko | CFO and CBO | 29 de enero de 2026 A | 279 980 | 0 | 0 | $0 |
| Ebun Garner | Chief Legal Officer | 1 de abril de 2026 M | 25 076 | 0 | 2 | $-1 982 800 |
| Shannon Morris | Chief Medical Officer | 4 de marzo de 2025 M | 0 | 0 | 1 | $-300 800 |
| Lin Wei | Chief Medical Officer | 1 de febrero de 2023 A | 315 812 | 0 | 0 | $0 |
| James Arthur Bristol | Consejero | 26 de junio de 2026 A | 20 000 | 0 | 0 | $0 |
| Valerie Denise Harding Start | Consejero | 26 de junio de 2026 A | 20 000 | 0 | 0 | $0 |
| Pratik S Multani | Consejero | 26 de junio de 2026 A | 6 200 | 0 | 0 | $0 |
| Julie Hambleton | Consejero | 26 de junio de 2026 A | 6 000 | 0 | 0 | $0 |
| Alexander W. Casdin | Consejero | 26 de junio de 2026 A | 573 974 | 0 | 0 | $0 |
| Jean I Liu | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Michael David Varney | Consejero | 29 de enero de 2026 A | · | 0 | 0 | $0 |
| Chen Bihua | Consejero | 22 de junio de 2022 A | 10 505 553 | 0 | 0 | $0 |
| Charles S. Fuchs | · | 10 de agosto de 2026 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 35 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2,26% | 567 358 SH | 1 de octubre de 2026 | Diario |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,42% | 395 404 SH | 1 de octubre de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,93% | 252 386 NS | 31 de julio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,87% | 22 122 NS | 31 de julio de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,39% | 1 956 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,34% | 24 747 SH | 1 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,29% | 1 881 079 SH | 11 de septiembre de 2026 | Diario |
| ESSC · Strategy Shares | 0,28% | 5 493 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,26% | 3 448 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,23% | 2 068 727 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,22% | 244 429 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,22% | 214 594 SH | 19 de agosto de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,17% | 8 052 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 59 277 NS | 31 de julio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,13% | 105 514 NS | 31 de julio de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 21 102 SH | 1 de octubre de 2026 | Diario |
| IWM · iShares Trust | 0,12% | 5 643 821 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 1 151 944 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 100 557 SH | 1 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 2 745 733 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 85 467 NS | 31 de julio de 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 81 147 SH | 11 de septiembre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,04% | 467 663 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,03% | 263 455 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 10 485 SH | 11 de septiembre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,02% | 402 637 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 8 386 105 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16 688 SH | 19 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 334 866 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 59 143 SH | 11 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 33 981 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18 981 NS | 31 de julio de 2026 | N-PORT |
| ISCB · iShares Trust | · | 9 786 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 48 754 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 239 252 SH | 11 de septiembre de 2026 | Diario |
ERAS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 17 analistas
COMPRA
Objetivo mediano
$22.00
+49,3%
5 29,4%
Compra fuerte
9 52,9%
Compra
3 17,6%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
9 analistas · 2026-09-27Objetivo medio $24.11 +63,6%
← Por Debajo de Todos los Objetivos
Precio Actual $14.74
Mín$20.00
Media$24.11
Máx$33.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20
Yahoo Finance · 3 meses, 4 semanas atrás
Por qué este fondo hizo una apuesta de $189 millones en Erasca mientras las acciones se disparan un 800%
Nasdaq · 4 meses atrás
Acuta Capital apuesta por Erasca (ERAS) y tratamientos oncológicos dirigidos con una compra de 354.575 acciones
Nasdaq · 4 meses, 2 semanas atrás
JPMorgan Recomienda Comprar Acciones de Erasca (ERAS) a Niveles Actuales
Yahoo Finance · 4 meses, 3 semanas atrás
Erasca (ERAS) Sube un 390% en lo que va del año gracias al potencial 'best-in-class' de su tratamiento contra el cáncer
Yahoo Finance · 5 meses, 2 semanas atrás
Qué Impulsa el Retorno YTD de Casi 355% de Erasca (ERAS)
Yahoo Finance · 5 meses, 3 semanas atrás
Erasca (ERAS) Suma 13%; Se Dispara 310% Año hasta la Fecha
Yahoo Finance · 6 meses, 1 semana atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026